Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9016323 | Progress in Neuro-Psychopharmacology and Biological Psychiatry | 2005 | 6 Pages |
Abstract
Ziprasidone induces lower D2 RO and EPS than haloperidol, which is consistent with an atypical antipsychotic profile. A direct relationship of ziprasidone D2 RO with dose, clinical efficacy and EPS has been found in this study. These data suggest that high ziprasidone doses might be more beneficial in patients with psychosis exacerbation and claim for caution regarding EPS appearance with such high dosages.
Keywords
Related Topics
Life Sciences
Neuroscience
Biological Psychiatry
Authors
Iluminada Corripio, Ana M. Catafau, VÃctor Perez, Dolors Puigdemont, Esther Mena, Yolanda Aguilar, Ignasi Carrió, Enric Álvarez,